NCT07011810 - Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

August 10, 2028

Study Completion Date

February 10, 2030

Conditions

Chronic Graft Versus Host Disease

Interventions

BIOLOGICAL

Axatilimab

Given IV

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Skin Biopsy

Undergo optional skin biopsy

PROCEDURE

Skin Measurement

Undergo optional skin flexibility assessment

Trial Locations (3)

NOT_YET_RECRUITING

Moffitt Cancer Center, Tampa

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

NOT_YET_RECRUITING

Dana-Farber Cancer Institute, Boston